Paragon Associates & Paragon Associates II Joint Venture’s Humana HUM Stock Holding History

Paragon Associates & Paragon Associates II Joint Venture’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,000	Closed	-$1.39M	–	14
2024 Q1	$1.39M	Buy	+4,000	New	+$1.52M	2.47%	14
2020 Q1	–	Sell	-50,000	Closed	-$18.3M	–	18
2019 Q4	$18.3M	Hold	50,000	–	–	10.3%	2
2019 Q3	$12.8M	Buy	50,000 +5,000	+11%	+$1.4M	9.86%	3
2019 Q2	$11.9M	Buy	+45,000	New	+$11.4M	9.2%	2

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Paragon Associates & Paragon Associates II Joint Venture's HUM Position: Q2 2024 in Review

Paragon Associates & Paragon Associates II Joint Venture sold out of Humana (HUM) in Q2 2024, closing a stake of 4,000 shares — an estimated $1.39M sold.

Paragon Associates & Paragon Associates II Joint Venture first reported a position in HUM in Q2 2019 and held it in 4 quarters. The position peaked at $18.3M in Q4 2019. 980 funds tracked by Wall St. Rank hold HUM as of Q2 2024.

Paragon Associates & Paragon Associates II Joint Venture reported no remaining Humana position as of Q2 2024 after selling out during the quarter.
Paragon Associates & Paragon Associates II Joint Venture sold 4,000 Humana shares in Q2 2024, an estimated $1.39M.
Paragon Associates & Paragon Associates II Joint Venture first reported a position in Humana in Q2 2019 and held it in 4 quarters.
Paragon Associates & Paragon Associates II Joint Venture's Humana position peaked at $18.3M in Q4 2019.
980 funds tracked by Wall St. Rank held Humana as of Q2 2024.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q2 2024, filed 13 Aug 2024.